CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC:

# Drug Count
0 GABAPENTIN 6
1 BACLOFEN 5
2 LEVETIRACETAM 5
3 DIVALPROEX SODIUM 4
4 ENOXAPARIN SODIUM 4
5 EXTENDED PHENYTOIN SODIUM 4
6 LACTULOSE 4
7 LAMOTRIGINE 4
8 LISINOPRIL 4
9 SERTRALINE HYDROCHLORIDE 4
See all common drugs associated with CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC

CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR HUMAN 1 0.0007
1 OMEGA-3-ACID ETHYL ESTERS 1 0.0005
2 PILOCARPINE HYDROCHLORIDE 1 0.0004
3 EXTENDED PHENYTOIN SODIUM 4 0.0002
4 FINGOLIMOD HYDROCHLORIDE 1 0.0002
5 ELETRIPTAN HYDROBROMIDE 1 0.0001
6 PROGESTERONE 3 0.0001
7 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1 0.0001
8 TEMAZEPAM 4 0.0001
9 LACTULOSE 4 0.0001
See all drugs enriched for association with CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC

CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progesterone [EPC] 3 0.0001
1 Barbiturate [EPC] 1 0.0001
2 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 5 0.0001
4 Antimycobacterial [EPC] 1 0.0000
5 Nucleoside Analog Antiviral [EPC] 3 0.0000
6 Mood Stabilizer [EPC] 6 0.0000
7 Anti-epileptic Agent [EPC] 5 0.0000
8 Muscle Relaxant [EPC] 1 0.0000
9 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CEREBRAL ARTERIOVENOUS MALFORMATION HAEMORRHAGIC